Review Article
Thermal Water Applications in the Treatment of Upper Respiratory Tract Diseases: A Systematic Review and Meta-Analysis
Table 6
Results of nasal flow.
| | Patients | NasFlow | CI 95% | value |
| Thermal (sulphur + radon) | | | | | Baseline | 97 | 604.1 | [513.68; 694.45] | | 12–14 days | 97 | 721.5 | [697.18; 745.84) | <0.0 | Placebo | | | | | Baseline | 20 | 714.3 | [664.13; 764.47] | | 12–14 days | 20 | 687.5 | [644.79; 730.21] | 0.425 | Radon | | | | | Baseline | 60 | 633.4 | [540.95; 725.90] | | 12–14 days | 60 | 738.8 | [703.64; 773.89] | <0.0 | Sulphur | | | | | Baseline | 37 | 558.4 | [526.53; 590.27] | | 12–14 days | 37 | 705.6 | [671.86; 739.34] | <0.0 |
|
|
Significant in comparison to baseline ().
|